Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

Language recovery after stroke
App | Video | PDF (278 pp) | Web


  Free Subscription


1 Am J Clin Pathol
2 Am J Hematol
1 Ann Hematol
3 Blood
1 Eur J Immunol
4 Leuk Lymphoma
4 Leuk Res
1 N Engl J Med
4 PLoS One

  Retrieve available abstracts of this week’s articles:
HTML format
Text format
Single Articles

    Am J Clin Pathol

  1. KLAIRMONT MM, Hoskoppal D, Yadak N, Choi JK, et al
    The Comparative Sensitivity of Immunohistochemical Markers of Megakaryocytic Differentiation in Acute Megakaryoblastic Leukemia.
    Am J Clin Pathol. 2018 Jul 25. pii: 5059214. doi: 10.1093.
    PubMed     Text format     Abstract available

    Am J Hematol

  2. SIEGEL SE, Advani A, Seibel N, Muffly L, et al
    Treatment of young adults with Philadelphia-negative acute lymphoblastic leukemia and lymphoblastic lymphoma: Hyper-CVAD versus pediatric-inspired regimens.
    Am J Hematol. 2018 Jul 30. doi: 10.1002/ajh.25229.
    PubMed     Text format     Abstract available

  3. ROSENTHAL J, Naqvi AS, Luo M, Wertheim G, et al
    Heterogeneity of surface CD19 and CD22 expression in B lymphoblastic leukemia.
    Am J Hematol. 2018 Jul 30. doi: 10.1002/ajh.25235.
    PubMed     Text format     Abstract available

    Ann Hematol

  4. SCHNEIDAWIND C, Hagmaier V, Faul C, Kanz L, et al
    Second allogeneic hematopoietic cell transplantation enables long-term disease-free survival in relapsed acute leukemia.
    Ann Hematol. 2018 Jul 31. pii: 10.1007/s00277-018-3454.
    PubMed     Text format     Abstract available


  5. LI W, Chastain K
    NUT midline carcinoma with leukemic presentation mimicking CD34-positive acute leukemia.
    Blood. 2018;132:456.
    PubMed     Text format    

    Cuplike nuclear morphology in pediatric B-cell acute lymphoblastic leukemia.
    Blood. 2018;132:457.
    PubMed     Text format    

  7. PIKMAN Y, Stegmaier K
    Targeted therapy for fusion-driven high-risk acute leukemia.
    Blood. 2018 Jul 26. pii: blood-2018-04-784157. doi: 10.1182/blood-2018-04-784157
    PubMed     Text format     Abstract available

    Eur J Immunol

  8. ZOU Y, Luo W, Guo J, Luo Q, et al
    NK cell-mediated anti-leukemia cytotoxicity is enhanced using a NKG2D ligand MICA and anti-CD20 scfv chimeric protein.
    Eur J Immunol. 2018 Jul 31. doi: 10.1002/eji.201847550.
    PubMed     Text format     Abstract available

    Leuk Lymphoma

  9. RUAN J, Gao S, Yang J, Li H, et al
    WT1 protein is cleaved by caspase-3 in apoptotic leukemic cells.
    Leuk Lymphoma. 2018;59:162-170.
    PubMed     Text format     Abstract available

  10. THORP BC, Badoux X
    Atrial fibrillation as a complication of ibrutinib therapy: clinical features and challenges of management.
    Leuk Lymphoma. 2018;59:311-320.
    PubMed     Text format     Abstract available

  11. IMBERT V, Nebout M, Mary D, Endou H, et al
    Co-targeting intracellular pH and essential amino acid uptake cooperates to induce cell death of T-ALL/LL cells.
    Leuk Lymphoma. 2018;59:460-468.
    PubMed     Text format     Abstract available

  12. OLSHANSKAYA Y, Kazakova A, Tsaur G, Zerkalenkova E, et al
    Clinical significance of cytogenetic changes in childhood T-cell acute lymphoblastic leukemia: results of the multicenter group Moscow-Berlin (MB).
    Leuk Lymphoma. 2018 Aug 1:1-7. doi: 10.1080/10428194.2018.1485904.
    PubMed     Text format     Abstract available

    Leuk Res

  13. RADIVOYEVITCH T, Dean RM, Shaw BE, Brazauskas R, et al
    Risk of acute myeloid leukemia and myelodysplastic syndrome after autotransplants for lymphomas and plasma cell myeloma.
    Leuk Res. 2018 Jul 19. pii: S0145-2126(18)30160.
    PubMed     Text format     Abstract available

  14. ROUSSELOT P, Renard P, de Buyer A, Finet A, et al
    Nivolumab to control molecular response in chronic myeloid leukemia.
    Leuk Res. 2018;72:5-6.
    PubMed     Text format    

  15. WANG YZ, Hao L, Chang Y, Jiang Q, et al
    A seven-color panel including CD34 and TdT could be applied in >97% patients with T cell lymphoblastic leukemia for minimal residual disease detection independent of the initial phenotype.
    Leuk Res. 2018;72:12-19.
    PubMed     Text format     Abstract available

  16. HEIBLIG M, Elhamri M, Thomas X, Plesa A, et al
    A phase 1 study of chemosensitization with plerixafor plus G-CSF in adults with relapsed acute myeloid leukemia.
    Leuk Res. 2018;72:7-11.
    PubMed     Text format    

    N Engl J Med

    Tipping Clonal Hematopoiesis into Transformation.
    N Engl J Med. 2018;379:295-296.
    PubMed     Text format    

    PLoS One

  18. CHACHAJ A, Wisniewski J, Rybka J, Butrym A, et al
    Asymmetric and symmetric dimethylarginines and mortality in patients with hematological malignancies-A prospective study.
    PLoS One. 2018;13:e0197148.
    PubMed     Text format     Abstract available

  19. NAGEL S, Meyer C, Kaufmann M, Zaborski M, et al
    Aberrant activity of NKL homeobox gene NKX3-2 in a T-ALL subset.
    PLoS One. 2018;13:e0197194.
    PubMed     Text format     Abstract available

  20. CLARISSE D, Van Wesemael K, Tavernier J, Offner F, et al
    Effect of combining glucocorticoids with Compound A on glucocorticoid receptor responsiveness in lymphoid malignancies.
    PLoS One. 2018;13:e0197000.
    PubMed     Text format     Abstract available

  21. MOORE TC, Messer RJ, Hasenkrug KJ
    Regulatory T cells suppress virus-specific antibody responses to Friend retrovirus infection.
    PLoS One. 2018;13:e0195402.
    PubMed     Text format     Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Leukemia is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.